Back to search

Article

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression

2024-01-15

Abstract excerpt

<title>Abstract</title> <p>Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men, and treatment options for metastatic disease remain limited. In this study, we employed Adeno-associated virus (AAV) delivery and CRISPR-Cas9 technology to simultaneously mutate multiple genes in the mouse prostate, in order to investigate positive genetic interactions during PCa progression. By targeting...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af465d12-5bdb-5f71-96f4-7f0dd7839c37
DOI
10.21203/rs.3.rs-3013972/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionDOI 10.21203/rs.3.rs-3013972/v1
Select a neighboring publication to make it the new centre.